Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators.

Products, services, technology
  • M4 PAM - Schizophrenia and other psychosis - Started IND enabling studies in Q3 2024
  • mGlu7 NAM - Mood disorders - Start IND enabling studies in H1 2025
  • mGlu2 NAM - Cognition - Enter clinical candidate selection in H1 2025
  • Undisclosed - CNS - Start lead optimization in H1 2025
Location
Additional address info
  • Campus Biotech - 5th floor
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2024
  • Number of employees in Switzerland
    10-19
Key business

You may also be interested in